GGrantIndex
← Leaderboards

Jian Yu

University Of Pittsburgh At Pittsburgh

$10,881,915
Attributed
$11,549,650
Total exposure
6
Grants
5
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.

Funding over time

peak $1.4M · FY200825
$2M$1.5M$1M$500K$0
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25

Funding mix

By agency

NIH$11,549,650 · 6

By mechanism

R01$7,676,551 · 4
U01$2,216,794 · 1
U19$1,656,305 · 1

Top collaborators

Most similar at University Of Pittsburgh At Pittsburgh

Same institution · by research overlap

Others in their field

Top investigators on “Cells

Research focus

CellsMediatingResponseApoptosisCell SurvivalCessation Of LifePlayIn VivoPathway InteractionsCell DeathPublic Health RelevanceIn VitroDna DamageAnimalsIntestinesAdultRadiationDoseLeadBone MarrowMolecularMouse ModelStem CellsTissues

Grant awards (32)

STING-dependent Intestinal Regeneration upon Radiation Injury$997,217
R01 · FY2025 · CA · contact PI
STING-dependent Intestinal Regeneration upon Radiation Injury$474,148
R01 · FY2024 · CA · contact PI
STING-dependent Intestinal Regeneration upon Radiation Injury$494,501
R01 · FY2023 · CA · contact PI
STING-dependent Intestinal Regeneration upon Radiation Injury$501,288
R01 · FY2022 · CA · contact PI
Translation addiction and targeting in colon cancer$459,802
R01 · FY2022 · CA · contact PI
Targeting defective necroptosis in colorectal cancer$430,693
R01 · FY2022 · CA
Translation addiction and targeting in colon cancer$469,185
R01 · FY2021 · CA · contact PI
Targeting defective necroptosis in colorectal cancer$443,378
R01 · FY2021 · CA
Translation addiction and targeting in colon cancer$469,185
R01 · FY2020 · CA · contact PI
Targeting defective necroptosis in colorectal cancer$461,400
R01 · FY2020 · CA
Translation addiction and targeting in colon cancer$455,111
R01 · FY2019 · CA · contact PI
Targeting Intestinal Stem Cell Dysfunctions in Radiation Mitigation$349,908
U19 · FY2019 · AI · contact PI
Translation addiction and targeting in colon cancer$467,690
R01 · FY2018 · CA · contact PI
Targeting Intestinal Stem Cell Dysfunctions in Radiation Mitigation$323,626
U19 · FY2018 · AI · contact PI
Targeting Intestinal Stem Cell Dysfunctions in Radiation Mitigation$338,647
U19 · FY2017 · AI · contact PI
Targeting Intestinal Stem Cell Dysfunctions in Radiation Mitigation$322,062
U19 · FY2016 · AI · contact PI
Targeting Intestinal Stem Cell Dysfunctions in Radiation Mitigation$322,062
U19 · FY2015 · AI · contact PI
Intestinal Stem Cell Survival and Renewal Coordinately Regulated by PUMA and p21$73,002
U01 · FY2014 · DK · contact PI
Intestinal Stem Cell Survival and Renewal Coordinately Regulated by PUMA and p21$358,922
U01 · FY2013 · DK · contact PI
Intestinal Stem Cell Survival and Renewal Coordinately Regulated by PUMA and p21$79,300
U01 · FY2013 · DK · contact PI
Intestinal Stem Cell Survival and Renewal Coordinately Regulated by PUMA and p21$378,750
U01 · FY2012 · DK · contact PI
Role of PUMA in EGFR targeted therapy in HNSCC$304,932
R01 · FY2012 · CA · contact PI
Intestinal Stem Cell Survival and Renewal Coordinately Regulated by PUMA and p21$65,575
U01 · FY2012 · DK · contact PI
Intestinal Stem Cell Survival and Renewal Coordinately Regulated by PUMA and p21$378,750
U01 · FY2011 · DK · contact PI
Role of PUMA in EGFR targeted therapy in HNSCC$304,932
R01 · FY2011 · CA · contact PI
Intestinal Stem Cell Survival and Renewal Coordinately Regulated by PUMA and p21$49,995
U01 · FY2011 · DK · contact PI
Intestinal Stem Cell Survival and Renewal Coordinately Regulated by PUMA and p21$378,750
U01 · FY2010 · DK · contact PI
Role of PUMA in EGFR targeted therapy in HNSCC$314,363
R01 · FY2010 · CA · contact PI
Intestinal Stem Cell Survival and Renewal Coordinately Regulated by PUMA and p21$75,000
U01 · FY2010 · DK · contact PI
Intestinal Stem Cell Survival and Renewal Coordinately Regulated by PUMA and p21$378,750
U01 · FY2009 · DK · contact PI
Role of PUMA in EGFR targeted therapy in HNSCC$314,363
R01 · FY2009 · CA · contact PI
Role of PUMA in EGFR targeted therapy in HNSCC$314,363
R01 · FY2008 · CA · contact PI